Skip to content
Community, Medical Health Aged Care

Patients welcome better access to Shingrix® for immunocompromised patients

Better Access Australia and AusPIPS Inc < 1 mins read
  • Media:

Shingles is a painful and difficult disease, but the length and severity of the disease in immunocompromised people can often be compounded and exacerbate already complex health conditions.

AusPIP and BAA have been advocating for expanded access to Shingrix® after the 2023-24 federal budget funding decision limited access to only those “immunocompromised patients aged 18 years and over with: haemopoietic stem cell transplant; solid organ transplant; haematological malignancy; and advanced or untreated HIV.

This denied funded access to patients with common and complex immunocompromised need patients like those with primary and secondary immunodeficiency. It also denied access to patients with immune system vulnerabilities as a result of treatments for common chronic diseases such as diabetes, arthritis, chronic obstructive pulmonary disorder and multiple sclerosis without subsidised access.

From 30 August 2024 funded access to Shingrix® has been expanded to include anyone “18 years and over considered at increased risk of herpes zoster due to an underlying condition and/or immunosuppressive treatments

BAA and AusPIPs have welcomed the decision and issued the attached media release with comments from both organisations about the important first step this represents in modernising Australia's approach to adult vaccination and the important role it plays in preventative health  for adults particularly with the increasing use of treatment that impact the immune system as part of better chronic disease management.

Quotes for attribution and Quick facts attached in full press release. 


Key Facts:

This vaccine was listed on the ARTG 1950 days before it was subsidised on the National Immunisation Program 

#100days


About us:

AusPIPS Inc represents primary and secondary immunodeficient (PID SID) patients in Australia, and Better Access Australiaworks with patients groups to advocate for improved health, disability and social services in Australia.


Contact details:

BAA: fmcneill@betteraccessaustralia.org.au

AusPIPS president@auspips.org.au

Media

Attachments

MR240905-Better-access-to-Shingrix-for-immunocompromised-patients.pdf

Download media

More from this category

  • Medical Health Aged Care
  • 05/04/2025
  • 09:25
Royal Australian College of GPs

GPs back WA flu vaccination program

The Royal Australian College of GPs (RACGP) is throwing its support behind Western Australia's influenza vaccination drive. It comes following the state Government announcing the free flu vaccination program starting 1 May this year for allWA residents aged six months and over. The RACGP has been urging patients to prepare for the peak flu season following concerning reports of record case numbers this year. Australia has already recorded more than 48,000 cases of lab-confirmed influenza this year, which is 50% higher than this time last year. RACGP Vice President and WA chair, Dr Ramya Raman, encouraged patients to roll up…

  • Medical Health Aged Care
  • 05/04/2025
  • 06:01
Dementia Australia

Join us today for the Victor Harbor Memory Walk & Jog!

What: Dementia Australia’s Victor Harbor Memory Walk & Jog    When: Saturday, 5 April from 9:00am   Who: More than 90 locals participating on the day. People who have been impacted by dementia, their family, friends and carers.   Where: Soldiers Memorial Gardens, Victor Harbor   Dementia Australia spokespeople and local residents are available for interview. Photos and video of previous Memory Walk & Jog events for publication are available for use. For more information visit: www.memorywalk.com.au Dementia Australia is the source of trusted information, education and services for the estimated more than 433,300 Australians living with dementia, and the more than…

  • Contains:
  • Medical Health Aged Care, Science
  • 04/04/2025
  • 13:21
La Trobe University

Scientists reveal new toxin that damages the gut

Scientists at La Trobe University have discovered how a diarrhoea-causing strain of bacteria uses “molecular scissors” to cut open and destroy gut cells, leading to severe illness and sometimes death. Published inGut Microbes, the research reveals for the first time the three-dimensional structure of a toxin secreted by enteropathogenicE. coli(EPEC) bacteria, and shows how the bacteria use the toxin to invade and destroy the epithelial cells that line the gut. The toxin, which is an enzyme called EspC, destroys the cells by cutting up their internal protein structure. La Trobe University scientist Professor Begoña Heras, who co-led the research, said…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.